Pubfacts - Scientific Publication Data
  • Categories
  • |
  • Journals
  • |
  • Authors
  • Login
  • Categories
  • Journals

Search Our Scientific Publications & Authors

Publications
  • Publications
  • Authors
find publications by category +
Translate page:

Sporadic colorectal polyps and mismatch repair proteins.

Authors:
Mahsa Molaei Mahdi Yadollahzadeh Shohreh Almasi Sepideh Shivarani Seyed Reza Fatemi Mohammad Reza Zali

Indian J Pathol Microbiol 2011 Oct-Dec;54(4):725-9

Department of Pathology, Research Center for Gastroenterology and Liver disease, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Background: Colorectal cancers often arise from benign polyps. Adenomatous polyps and serrated polyps progress step by step to adenocarcinoma and change into malignant cancers. Genetic and epigenetic changes have correlation with specific stages of polyp-adenocarcinoma progression and colorectal cancer histopathological changes.

Aims: In this study we used immunohistochemistry (IHC) staining in sporadic colorectal polyps to assay functional status of MLH1, MSH2, MSH6, and PMS2 proteins, to track genetic/epigenetic roles of this issue in our patients.

Materials And Methods: In this cross-sectional study we assessed all patients who were admitted with sporadic colorectal polyps and underwent polypectomy in endoscopy department during 2004-2008.

Result: IHC results were abnormal in 6.8% cases for MLH1, in 4.5% cases for MSH2, in 3% for MSH6, and in 4.8% for PMS2. In all cases with abnormal PMS2, MLH1 was also reported as abnormal. Same results were reported for abnormal MSH2, which is accompanied with abnormal MSH6 in all cases (P values < 0.001). There is no significant difference between IHC staining results, gender, dysplasia grade, adenomatous type, and invasion. On the other hand, there was significant difference between IHC staining results, polyp location, and mean age of patients. The same significant difference was between adenomatous polyps and serrated adenoma polyps by MLH1 and PMS2 (P values < 0.05).

Conclusion: According to our findings, maybe MMR dysfunction is the cause of sporadic colorectal polyps in younger age and its increasing risk of dysplasia progression and malignancy progression is only in serrated adenoma. Sporadic polyps in left colon had a higher risk to progress to malignancies, and abnormal IHC staining for MLH1 and PMS2 in serrated polyps is much more than in other adenomatous polyps.

Download full-text PDF

Source
http://dx.doi.org/10.4103/0377-4929.91505DOI Listing
April 2012

Publication Analysis

Top Keywords

ihc staining
16
colorectal polyps
16
sporadic colorectal
16
adenomatous polyps
12
polyps
12
polyps serrated
8
polyps adenomatous
8
serrated polyps
8
difference ihc
8
mlh1 pms2
8
serrated adenoma
8
reported abnormal
8
msh2 msh6
8
abnormal
6
sporadic
5
pms2
5
mlh1
5
colorectal
5
ihc
5
pms2 mlh1
4

Keyword Occurance

Similar Publications

Intratumor heterogeneity is biomarker specific and challenges the association with heterogeneity in multimodal functional imaging in head and neck squamous cell carcinoma.

Authors:
Jacob H Rasmussen Anders B Olin Giedrius Lelkaitis Adam E Hansen Flemming L Andersen Helle H Johannesen Andreas Kjaer Barbara M Fischer Lena Specht Søren M Bentzen Christian von Buchwald Irene Wessel Ivan R Vogelius

Eur J Radiol 2021 Mar 31;139:109668. Epub 2021 Mar 31.

Department of Oncology, Section of Radiotherapy, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.

Rationale: Tumor biopsy cannot detect heterogeneity and an association between heterogeneity in functional imaging and molecular biology will have an impact on both diagnostics and treatment possibilities.

Purpose: Multiparametric imaging can provide 3D information on functional aspects of a tumor and may be suitable for predicting intratumor heterogeneity. Here, we investigate the correlation between intratumor heterogeneity assessed with multiparametric imaging and multiple-biopsy immunohistochemistry. Read More

View Article and Full-Text PDF
March 2021
Similar Publications

Complement Detection in Human Tumors by Immunohistochemistry and Immunofluorescence.

Authors:
Marie V Daugan Margot Revel Laetitia Lacroix Catherine Sautès-Fridman Wolf H Fridman Lubka T Roumenina

Methods Mol Biol 2021 ;2227:191-203

INSERM, UMR_S 1138, Inflammation, Complement and Cancer Team, Centre de Recherche des Cordeliers, Sorbonne Universités, Université de Paris, Paris, France.

Tumors contain a complement rich microenvironment in which all cell types (e.g., tumor cells and stromal cells) are able to produce different proteins. Read More

View Article and Full-Text PDF
January 2021
Similar Publications

Prognostic Features of Biochemical Recurrence of Prostate Cancer Following Radical Prostatectomy Based on Multiparametric MRI and Immunohistochemistry Analysis of MRI-guided Biopsy Specimens.

Authors:
Stephanie A Harmon William Gesztes Denise Young Sherif Mehralivand Yolanda McKinney Thomas Sanford Jonathan Sackett Jennifer Cullen Inger L Rosner Shiv Srivastava Maria J Merino Bradford J Wood Peter A Pinto Peter L Choyke Albert Dobi Isabell A Sesterhenn Baris Turkbey

Radiology 2021 Apr 13:202425. Epub 2021 Apr 13.

From the Clinical Research Directorate, Frederick National Laboratory for Cancer Research sponsored by the National Cancer Institute (S.A.H.); Molecular Imaging Branch (S.A.H., S.M., Y.M., T.S., J.S., P.L.C., B.T.), Laboratory of Pathology (M.J.M.), Center for Interventional Oncology (B.J.W.), and Urologic Oncology Branch (S.M., P.A.P.), National Cancer Institute, National Institutes of Health, 9000 Rockville Pike, Building 10, Room B3B85, Bethesda, Md 20892; Center for Prostate Disease Research, John P. Murtha Cancer Center, Department of Surgery, Uniformed Services University of the Health Sciences (W.G., D.Y., J.C., I.L.R., S.S., A.D., I.A.S.) and Urology Service (I.L.R.), Walter Reed National Military Medical Center, Bethesda, Md; and Department of Genitourinary Pathology, Joint Pathology Center, Silver Spring, Md (I.A.S.).

Background Although prostate MRI is routinely used for the detection and staging of localized prostate cancer, imaging-based assessment and targeted molecular sampling for risk stratification are an active area of research. Purpose To evaluate features of preoperative MRI and MRI-guided biopsy immunohistochemistry (IHC) findings associated with biochemical recurrence (BCR) of prostate cancer after surgery. Materials and Methods In this retrospective case-control study, patients underwent multiparametric MRI before MRI-guided biopsy followed by radical prostatectomy between 2008 and 2016. Read More

View Article and Full-Text PDF
April 2021
Similar Publications

GSG2 knockdown suppresses cholangiocarcinoma progression by regulating cell proliferation, apoptosis and migration.

Authors:
Jun Zhou Wanpin Nie Jiajia Yuan Zeyu Zhang Liangliang Mi Changfa Wang Ranglang Huang

Oncol Rep 2021 Jun 13;45(6). Epub 2021 Apr 13.

Department of Hepatobiliary and Pancreatic Surgery, The Third Xiangya Hospital of The Central South University, Changsha, Hunan 410013, P.R. China.

Cholangiocarcinoma (CCA) is the second most common type of hepatocellular carcinoma characterized by high aggressiveness and extremely poor patient prognosis. The germ cell‑specific gene 2 protein (GSG2) is a histone H3 threonine‑3 kinase required for normal mitosis. Nevertheless, the role and mechanism of GSG2 in the progression and development of CCA remain elusive. Read More

View Article and Full-Text PDF
June 2021
Similar Publications

Distinct prognostic values of programmed death-ligand 1 and programmed cell death protein 1 in lung adenocarcinoma and squamous cell carcinoma patients.

Authors:
Shuo Wang Xiujuan Qu Zhi Li Xiaofang Che Lili Cao Xianghong Yang Xuejun Hu Ling Xu Kezuo Hou Yibo Fan Ti Wen Yunpeng Liu

Ann Transl Med 2021 Mar;9(5):397

Department of Medical Oncology, the First Hospital of China Medical University, Shenyang, China.

Background: Although immunotherapy has demonstrated similar clinical activities in the treatment of lung adenocarcinoma (ADC) and squamous cell carcinoma (SCC), several studies have shown programmed death-ligand 1 (PD-L1) to have different predictive roles in ADC and SCC. This study was conducted to compare the different functions of PD-L1/programmed cell death protein 1 (PD-1) pathway in these malignancies.

Methods: A multi-dimensional analysis based on public databases and 2 independent cohorts including 262 patients with lung cancer was performed. Read More

View Article and Full-Text PDF
March 2021
Similar Publications
© 2021 PubFacts.
  • About PubFacts
  • Privacy Policy
  • Sitemap